Verantos Announces Breakthrough in Non-alcoholic Steatohepatitis Real-world Evidence
Researchers open new opportunities to address liver disease. PALO ALTO, Calif., March 24, 2022 /PRNewswire/ — Verantos, the market leader in high-validity real-world evidence generation, announced that along with its research partners, the...